Related references
Note: Only part of the references are listed.Phenotypic and Genetic Characterization of Lower LDL Cholesterol and Increased Type 2 Diabetes Risk in the UK Biobank
Yann C. Klimentidis et al.
DIABETES (2020)
Identification of C2CD4A as a human diabetes susceptibility gene with a role in β cell insulin secretion
Taiyi Kuo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks
Rachana Haliyur et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The cell biology of systemic insulin function
Victoria L. Tokarz et al.
JOURNAL OF CELL BIOLOGY (2018)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years
Luiz Sergio F. de Carvalho et al.
DIABETES CARE (2018)
Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance
Robert Wagner et al.
DIABETES (2017)
Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects
Andrea Natali et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
New onset diabetes mellitus induced by statins: current evidence
Steven G. Chrysant
POSTGRADUATE MEDICINE (2017)
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
Amand F. Schmidt et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Single-Cell Analysis of Human Pancreas Reveals Transcriptional Signatures of Aging and Somatic Mutation Patterns
Martin Enge et al.
CELL (2017)
Diabetes Secondary to Treatment with Statins
Markku Laakso et al.
CURRENT DIABETES REPORTS (2017)
Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity
Martin Heni et al.
DIABETOLOGIA (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Joost Besseling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow et al.
LANCET (2015)
Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy Effect of Baseline Risk Factors for Diabetes
David D. Waters et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Rab6, Rab8, and MICAL3 Cooperate in Controlling Docking and Fusion of Exocytotic Carriers
Ilya Grigoriev et al.
CURRENT BIOLOGY (2011)
Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Pancreatic Islet α-Cells and Promotes Insulin Secretion
Yukihiro Fujita et al.
GASTROENTEROLOGY (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells
Sabine Ruetti et al.
ENDOCRINOLOGY (2009)
Carcinoembryonic antigen-related cell adhesion molecule 1 - A link between insulin and lipid metabolism
Anthony M. DeAngelis et al.
DIABETES (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
What is the best predictor of future type 2 diabetes?
Muhammad A. Abdul-Ghani et al.
DIABETES CARE (2007)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Insulin-secreting β-cell dysfunction induced by human lipoproteins
ME Roehrich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Low density lipoprotein can cause death of islet β-cells by its cellular uptake and oxidative modification
M Cnop et al.
ENDOCRINOLOGY (2002)
CEACAM1 regulates insulin clearance in liver
MN Poy et al.
NATURE GENETICS (2002)
Glucose uptake, utilization, and signaling in GLUT2-null islets
MT Guillam et al.
DIABETES (2000)
Share Paper
